Efficacy of intravenous immunoglobulins (IVIG) in COVID-19 patients: a systematic review and meta-analysis

Efficacy of intravenous immunoglobulins (IVIG) in COVID-19 patients: a systematic review and meta-analysis

Background and purpose: Though controversial, many clinical trials have been conducted to evaluate the efficacy of intravenous immunoglobulins (IVIG) in COVID-19 cases. Therefore, a systematic review and meta-analysis have been performed to evaluate the efficacy of IVIG in the treatment of COVID-19...

Full description

Bibliographic Details
Main Authors:	Behzad Fatemi, Soheila Rezaei, Mohammad Peikanpour, Farzaneh Dastan, Ali Saffaei
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Research in Pharmaceutical Sciences
Subjects:	clinical efficacy; intravenous immunoglobulin; meta-analysis; mortality rate; sars-cov-2 infection; systematic review
Online Access:	http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2023;volume=18;issue=4;spage=346;epage=357;aulast=Fatemi

Similar Items

Intravenous immunoglobulins (IVIG) in severe/critical COVID-19 adult patients
by: Dorota Kwapisz, et al.
Published: (2023-07-01)

Efficacy of intravenous immunoglobulin (IVIg) on COVID-19-related neurological disorders over the last 2 years: an up-to-date narrative review
by: Paolo Manganotti, et al.
Published: (2023-04-01)

Aseptic meningitis after intravenous immunoglobulin (IVIG) infusion in children with immune thrombocytopenic purpura (ITP)
by: A Tamaddoni, et al.
Published: (2001-04-01)

Plasma exchange (PE) versus intravenous immunoglobulin (IVIG) for the treatment of Guillain-Barré syndrome (GBS) in patients with severe symptoms: A systematic review and meta-analysis
by: Hany A. Zaki, et al.
Published: (2023-06-01)

Transient lymphadenopathy during intravenous immunoglobulin (IVIg) in a patient with pemphigus vulgaris
by: Delila Pouldar Foulad, et al.
Published: (2021-09-01)

A Systematic Review and Meta-Analysis of Immunoglobulin G Abnormalities and the Therapeutic Use of Intravenous Immunoglobulins (IVIG) in Autism Spectrum Disorder
by: Daniel A Rossignol, et al.
Published: (2021-05-01)

Injection of intravenous immunoglobulin (IVIg) for the treatment of Coronavirus induced cytokine storm
by: Farahnoosh Farnood, et al.
Published: (2022-12-01)

Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic Purpura
by: Zahra Farahmandinia, et al.
Published: (2010-10-01)

Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic Purpura
by: Zahra Farahmandinia, et al.
Published: (2010-12-01)

Intravenous Immunoglobulin Therapy in Myocarditis
by: Amir Hossein Mansourabadi, et al.
Published: (2020-08-01)

Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections
by: Carlo Perricone, et al.
Published: (2021-01-01)

INTRAVENOUS IMMUNOGLOBULIN THERAPY IN MEDICAL PRAXIS
by: Lidija Kareva
Published: (2016-12-01)

Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic Review
by: Daniele Focosi, et al.
Published: (2022-01-01)

Chronic inflammatory demyelinating polyradiculoneuropathy in patients with diabetes mellitus - treatment with intravenous immunoglobulins: A systematic review
by: Szymon Andrusiów, et al.
Published: (2023-08-01)

Myasthenia Crisis Vs Cholinergic Crisis: Challenges in Crisis Management Without Plasmapheresis or Intravenous Immunoglobulin (IVIG)
by: Lila Tri Harjana, et al.
Published: (2020-07-01)

EFFICACY OF INTRAVENOUS IMMUNOGLOBULINS IN COMPLEX TREATMENT OF PERINATAL INFECTIONS IN PRETERM NEONATES
by: V.A. Bushtyriev, et al.
Published: (2006-01-01)

Intravenous Immunoglobulin and its Complications
by: I Mohammadzadeh
Published: (2011-05-01)

An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis
by: MO Soares, et al.
Published: (2012-02-01)

Corticosteroids and Intravenous Immunoglobulin in Pediatric Myocarditis: A Meta-Analysis
by: Yining Li, et al.
Published: (2019-08-01)

"High Doses Intravenous Immunoglobulin versus Oral Cyclosporine in the Treatment of Severe Atopic Dermatitis "
by: "Mohammad Hassan Bemanian, et al.
Published: (2005-09-01)

The therapeutic window of intravenous immunoglobulin (IVIG) and its correlation with clinical outcomes in Kawasaki disease: a systematic review and meta-analysis
by: Zheng Li, et al.
Published: (2023-04-01)

INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS
by: V. A. Lazanovich, et al.
Published: (2014-08-01)

Evaluation of rational prescription pattern of intravenous immunoglobulin (IVIG) based on FDA-approved indications among teaching hospitals in Birjand
by: Abolfazl Abbaszadeh, et al.
Published: (2022-04-01)

Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) and intravenous immunoglobulin (IVIG): comprehensive open-label trial in ten children
by: Parisa Hajjari, et al.
Published: (2022-08-01)

Corrigendum: MIS-C Treatment: Is IVIG Always Necessary?
by: Francesco Licciardi, et al.
Published: (2022-02-01)

Adjuvant intravenous immunoglobulin administration on postoperative critically ill patients with secondary peritonitis: a retrospective study
by: Young Un Choi, et al.
Published: (2023-02-01)

IMMUNOREGULATORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS
by: S. A. Sel'kov, et al.
Published: (2014-07-01)

Successful treatment of COVID-19 induced neutrophilic myositis with intravenous immunoglobulin and corticosteroids: a case report
by: S. Assar, et al.
Published: (2022-02-01)

Side Effects of Intravenous Immunoglobulin Treatment in Neurological Disorders
by: Buket Oflazoğlu, et al.
Published: (2006-02-01)

Intravenous immunoglobulins for the treatment of prolonged COVID-19 in immunocompromised patients: a brief report
by: Bénédicte Billi, et al.
Published: (2024-04-01)

Efficacy and safety of intravenous daratumumab-based treatments for AL amyloidosis: a systematic review and meta-analysis
by: Chunyan Sun, et al.
Published: (2022-07-01)

Intravenous immunoglobulin in the treatment of severe Clostridium difficile colitis
by: Nihar Shah, et al.
Published: (2014-01-01)

Treatment of a case of COVID-19 by intravenous immunoglobulin
by: Mustafa Çolak, et al.
Published: (2021-03-01)

Intravenous immunoglobulin: Revisited – My experience
by: Sanjeev S Vaishampayan, et al.
Published: (2021-01-01)

Intravenous Immunoglobulin Therapy-Induced Erythema Multiforme in a Patient with Chronic Lymphocytic Leukemia
by: Angelina Konovalova, et al.
Published: (2023-10-01)

Stroke in a young adult receiving intravenous immunoglobulin therapy for immune thrombocytopenic purpura
by: Javed Iqbal Wani
Published: (2016-01-01)

Effectiveness of two same-manufacturer intravenous immunoglobulin for Kawasaki disease
by: Kun-Lang Wu, et al.
Published: (2024-04-01)

Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia
by: Hun-Ju Yu, et al.
Published: (2021-03-01)

LIVEdoid vasculopathy – benefit of intravenous immunoglobulin in a refractory case
by: Stefan Cristian Dinescu, et al.
Published: (2021-03-01)

Can low-dose intravenous immunoglobulin be an alternative to high-dose intravenous immunoglobulin in the treatment of children with newly diagnosed immune thrombocytopenia: a systematic review and meta-analysis
by: Xiangge Ren, et al.
Published: (2024-03-01)